Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12094-015-1436-2 http://scihub22266oqcxt.onion/10.1007/s12094-015-1436-2 C4689747!4689747!26607930     free     free     free       Clin+Transl+Oncol 2015 ; 17 (ä): 982-7 Nephropedia Template TP {{tp|p=26607930|t=2015. Biliary tract cancers: SEOM clinical guidelines |pdf=|usr=}}{{26607930}} gab.com Text Biliary tract cancers: SEOM clinical guidelines JO: Clin Transl Oncol http://www.kidney.de/pget.php?&tw=1&pmid=26607930 #FOAvip Biliary tract cancer (BTC) is an uncommon and highly fatal malignancy. It is composed of three main different entities; Gall bladder carcinoma (GBC), intrahepatic cholangiocarcinoma (iCC) and extrahepatic cholangiocarcinoma (eCC) sharing different genetic, risk factors and clinical presentation. Multidetector-row computed tomography (MDCT) and magnetic resonance cholangio-pancreatography (MRCP) are the more important diagnostic techniques. Surgery is the only potentially curative therapy but disease recurrence is frequent. Treatment with chemotherapy, radiotherapy or both has not demonstrated survival benefit in the adjuvant setting. Cisplatin plus gemcitabine constitutes the gold standard in metastatic disease. New ongoing studies mainly in the adjuvant and neoadjuvant setting along with molecular research will hopefully help to improve survival and quality of life of this disease. Twit Text FOAVip Biliary tract cancers: SEOM clinical guidelines ????Clin Transl Oncol http://www.kidney.de/pget.php?&tw=1&pmid=26607930 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26607930 #FOAvip English Wikipedia <ref>{{Cite pmid|26607930}}</ref> Biliary tract cancers: SEOM clinical guidelines #MMPMID26607930 Benavides M; Antón A; Gallego J; Gómez MA; Jiménez-Gordo A; La Casta A; Laquente B; Macarulla T; Rodríguez-Mowbray JR; Maurel J Clin Transl Oncol 2015[]; 17 (ä): 982-7 PMID26607930show ga Biliary tract cancer (BTC) is an uncommon and highly fatal malignancy. It is composed of three main different entities; Gall bladder carcinoma (GBC), intrahepatic cholangiocarcinoma (iCC) and extrahepatic cholangiocarcinoma (eCC) sharing different genetic, risk factors and clinical presentation. Multidetector-row computed tomography (MDCT) and magnetic resonance cholangio-pancreatography (MRCP) are the more important diagnostic techniques. Surgery is the only potentially curative therapy but disease recurrence is frequent. Treatment with chemotherapy, radiotherapy or both has not demonstrated survival benefit in the adjuvant setting. Cisplatin plus gemcitabine constitutes the gold standard in metastatic disease. New ongoing studies mainly in the adjuvant and neoadjuvant setting along with molecular research will hopefully help to improve survival and quality of life of this disease. äBiliary tract cancers: SEOM clinical guidelines (epmc).pdf DeepDyve Pubget Overpricing